These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15817380)

  • 1. Host factors regulating post-integration latency of HIV.
    Williams SA; Greene WC
    Trends Microbiol; 2005 Apr; 13(4):137-9. PubMed ID: 15817380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular basis of HIV-1 latency - part I: physiology of HIV-1 latency].
    Schwartz C; Le Douce V; Cherrier T; Redel L; Marban C; Aunis D; Rohr O
    Med Sci (Paris); 2010 Feb; 26(2):159-63. PubMed ID: 20188047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The multifactorial nature of HIV-1 latency.
    Lassen K; Han Y; Zhou Y; Siliciano J; Siliciano RF
    Trends Mol Med; 2004 Nov; 10(11):525-31. PubMed ID: 15519278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding HIV latency to undo it.
    Cohen J
    Science; 2011 May; 332(6031):786. PubMed ID: 21566174
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary cell models of HIV latency.
    Yang HC
    Curr Opin HIV AIDS; 2011 Jan; 6(1):62-7. PubMed ID: 21242895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR5 stimulation is sufficient to trigger reactivation of latent HIV-1 provirus in T lymphoid cells and activate virus gene expression in central memory CD4+ T cells.
    Thibault S; Imbeault M; Tardif MR; Tremblay MJ
    Virology; 2009 Jun; 389(1-2):20-5. PubMed ID: 19447460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latency: the hidden HIV-1 challenge.
    Marcello A
    Retrovirology; 2006 Jan; 3():7. PubMed ID: 16412247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy.
    Ikeda T; Shibata J; Yoshimura K; Koito A; Matsushita S
    J Infect Dis; 2007 Mar; 195(5):716-25. PubMed ID: 17262715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual activity of phosphorothioate CpG oligodeoxynucleotides on HIV: reactivation of latent provirus and inhibition of productive infection in human T cells.
    Scheller C; Ullrich A; Lamla S; Dittmer U; Rethwilm A; Koutsilieri E
    Ann N Y Acad Sci; 2006 Dec; 1091():540-7. PubMed ID: 17341643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Centrosomal pre-integration latency of HIV-1 in quiescent cells.
    Zamborlini A; Lehmann-Che J; Clave E; Giron ML; Tobaly-Tapiero J; Roingeard P; Emiliani S; Toubert A; de Thé H; Saïb A
    Retrovirology; 2007 Sep; 4():63. PubMed ID: 17845727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of human immunodeficiency virus-1 latency and its reactivation.
    Verdin E
    Bull Mem Acad R Med Belg; 2008; 163(6):355-64; discussion 364-5. PubMed ID: 19445107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional interference antagonizes proviral gene expression to promote HIV latency.
    Lenasi T; Contreras X; Peterlin BM
    Cell Host Microbe; 2008 Aug; 4(2):123-33. PubMed ID: 18692772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV latency and integration site placement in five cell-based models.
    Sherrill-Mix S; Lewinski MK; Famiglietti M; Bosque A; Malani N; Ocwieja KE; Berry CC; Looney D; Shan L; Agosto LM; Pace MJ; Siliciano RF; O'Doherty U; Guatelli J; Planelles V; Bushman FD
    Retrovirology; 2013 Aug; 10():90. PubMed ID: 23953889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Molecular Basis for Human Immunodeficiency Virus Latency.
    Mbonye U; Karn J
    Annu Rev Virol; 2017 Sep; 4(1):261-285. PubMed ID: 28715973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.
    Quivy V; De Walque S; Van Lint C
    Subcell Biochem; 2007; 41():371-96. PubMed ID: 17484137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of integration and clonal expansion in HIV infection: live long and prosper.
    Anderson EM; Maldarelli F
    Retrovirology; 2018 Oct; 15(1):71. PubMed ID: 30352600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.
    Williams SA; Chen LF; Kwon H; Ruiz-Jarabo CM; Verdin E; Greene WC
    EMBO J; 2006 Jan; 25(1):139-49. PubMed ID: 16319923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental approaches to the study of HIV-1 latency.
    Han Y; Wind-Rotolo M; Yang HC; Siliciano JD; Siliciano RF
    Nat Rev Microbiol; 2007 Feb; 5(2):95-106. PubMed ID: 17224919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. StpC-based gene therapy targeting latent reservoirs of HIV-1.
    Turner LS; Tsygankov AY; Henderson EE
    Antiviral Res; 2006 Dec; 72(3):233-41. PubMed ID: 16891001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.